CD59 and neoplasm: Downregulation of CD59, a membrane complement regulatory protein (mCRPs) that inhibits the cytolytic activity of complement, by a recombinant retrovirus encoding shRNA targeted human CD59, enhanced complement mediated cell damage, increasing apoptosis in vitro and inhibiting tumour growth in nude mice [74].